6.53k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the most active SPACs by daily trading volume.
Curated by Yahoo Finance
Follow this list to discover and track the most active SPACs by daily trading volume. Investopedia describes a special purpose acquisition company (SPAC) as "a company with no commercial operations that is formed strictly to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company." They are also known as "blank check companies."
SPACs revealed to investors and companies that there are faster and simpler ways to go public than a traditional IPO. If direct listings were previously the hype, SPACs are the new direct listing buzz today. In fact, SPACs have been around for decades and in recent years they have become more established as some notable companies have gone public through SPACs. Additionally, SPACs have attracted many high-profile names and investors which make them even more attractive.
The list includes stocks priced at $5 or more reflecting intraday volume. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.How are these weighted?
The stocks in this watchlist are weighted equally.
|Watchlist||Change today||1-month return||1-year return||Total return|
|Most Active SPACs||-1.30%||-||-||-|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|CCIV||Churchill Capital Corp IV||21.73||-0.36||-1.63%||16:00 GMT-4||11.71M||48.04M||5.62B|
|PSTH||Pershing Square Tontine Holdings, Ltd.||24.67||-0.05||-0.20%||16:00 GMT-4||1.56M||3.88M||4.93B|
|IPOE||Social Capital Hedosophia Holdings Corp. V||16.68||-0.15||-0.89%||16:00 GMT-4||2.40M||7.29M||1.68B|
|AGC||Altimeter Growth Corp.||14.4||-0.93||-6.07%||16:00 GMT-4||6.14M||1.05M||1.62B|
|IPOF||Social Capital Hedosophia Holdings Corp. VI||10.55||-0.09||-0.85%||16:00 GMT-4||1.68M||4.69M||1.52B|
|STPK||Star Peak Energy Transition Corp.||26.61||-0.43||-1.59%||16:00 GMT-4||1.74M||3.96M||1.28B|
|GSAH||GS Acquisition Holdings Corp II||10.51||-0.12||-1.13%||16:00 GMT-4||1.21M||3.44M||985.31M|
|AJAX||Ajax I||10.11||+0.03||+0.30%||16:00 GMT-4||984.90k||1.63M||904.27M|
|BOWX||BowX Acquisition Corp.||12.45||-1.10||-8.12%||16:00 GMT-4||1.43M||1.51M||751.67M|
|NGA||Northern Genesis Acquisition Corp.||16.18||-0.08||-0.49%||16:00 GMT-4||1.18M||2.17M||646.09M|
|MUDS||Mudrick Capital Acquisition Corporation II||13.24||-0.12||-0.90%||16:00 GMT-4||4.79M||1.73M||523.39M|
|FTCV||Fintech Acquisition Corp. V||12.9||-0.75||-5.49%||16:00 GMT-4||3.47M||1.94M||441.01M|
|SFTW||Osprey Technology Acquisition Corp.||10.07||-0.01||-0.10%||16:00 GMT-4||1.32M||2.34M||398.08M|
|HOL||Holicity Inc.||10.57||-0.33||-3.03%||16:00 GMT-4||1.66M||3.11M||396.37M|
|TSIA||TS Innovation Acquisitions Corp.||10.3||-0.14||-1.34%||16:00 GMT-4||1.18M||1.15M||386.25M|
|PSAC||Property Solutions Acquisition Corp.||11.69||-0.89||-7.07%||16:00 GMT-4||2.07M||2.24M||345.05M|
|VIH||VPC Impact Acquisition Holdings||13.28||-1.83||-12.11%||16:00 GMT-4||2.28M||1.03M||344.24M|
|BCTG||BCTG Acquisition Corp.||12.15||+0.93||+8.29%||16:00 GMT-4||1.17M||19.16k||259.73M|
|THCA||Tuscan Holdings Corp. II||10.1||+0.09||+0.90%||16:00 GMT-4||1.35M||284.01k||222.07M|
|RACA||Therapeutics Acquisition Corp.||10||-0.30||-2.91%||16:00 GMT-4||1.37M||85.17k||178.70M|
|TCVA||TCV Acquisition Corp. Class A Ordinary Shares||10.6||+0.60||+6.00%||16:00 GMT-4||6.48M||6.48M||-|
|GGPIU||Gores Guggenheim, Inc.||10.01||+0.01||+0.05%||16:00 GMT-4||3.55M||1.70M||-|
|SRNGU||Soaring Eagle Acquisition Corp.||10.59||-0.14||-1.30%||16:00 GMT-4||3.25M||4.86M||-|
|CCVI-UN||Churchill Capital Corp VI||10.3||-0.03||-0.29%||15:56 GMT-4||29.17k||834.91k||-|
|CVII-UN||Churchill Capital Corp VII||10.11||+0.01||+0.10%||15:59 GMT-4||216.03k||2.34M||-|
|CCV-UN||Churchill Capital Corp V||10.43||-0.03||-0.29%||15:59 GMT-4||1.57M||384.73k||-|
|PNTM-UN||Pontem Corporation||10.02||+0.02||+0.20%||15:58 GMT-4||1.54M||475.45k||-|
|ROSS-UN||Ross Acquisition Corp II||10.01||+0.02||+0.20%||16:00 GMT-4||1.49M||913.69k||-|
|SLAMU||Slam Corp.||10.03||+0.05||+0.50%||16:00 GMT-4||1.30M||1.36M||-|
|PUCK||Goal Acquisitions Corp.||9.75||+0.02||+0.21%||15:59 GMT-4||1.22M||110.60k||-|
Couples that move in with their parents to save on rent would need to live in their family home for 37 months in order to save a 10% deposit of £26,700.
Slam Corp. (NASDAQ: SLAMU) (the "Company") announced that, commencing April 15, 2021, holders of the units sold in the Company's initial public offering of 57,500,000 units, completed on February 25, 2021, may elect to separately trade the Class A ordinary shares and warrants included in the units. Those units not separated will continue to trade on the Nasdaq Stock Market LLC ("NASDAQ") under the symbol "SLAMU," and the Class A ordinary shares and warrants that are separated will trade on the NASDAQ under the symbols "SLAM" and "SLAMW," respectively. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and warrants.
The latest biotech-SPAC deal has arrived with Cambridge, Massachusetts-based Tango Therapeutics announcing its reverse merger with Boxer Capital’s blank-check company BCTG Acquisition Corp (NASDAQ: BCTG). With a spotlight on three lead programs, Tango expects total proceeds of $353 million in the deal, including around $167 million held in the SPAC and an additional $186 million in PIPE financing. When the deal closes, Tango’s stock is expected to list on the NASDAQ under the stock symbol “TNGX.” Tango develops drugs based on synthetic lethality, a concept that involves tapping into a genetic vulnerability in cancer. Its focus is on developing drugs that counteract the loss of tumor suppressor genes and reverse cancer cells’ ability to evade the immune system. Lead program TNG908 is designed to block PRMT5, an enzyme expressed at high levels in tumors and whose synthetic lethal pair is a gene called MTAP. The company plans to file FDA investigational new drug (IND) application by the end of this year. A second IND filing is planned for next year for an inhibitor of a cancer protein called USP1, which Tango intends to develop for BRCA1-mutant breast, ovarian, and prostate cancers. The third program for an undisclosed target is expected to reach the clinic in 2023 for lung cancer characterized by a mutation to the STK11 gene. The company also plans to continue work on preclinical compounds in its pipeline to file a new IND every 12 to 18 months. In 2018, Tango signed Gilead Sciences Inc (NASDAQ: GILD) to work together on five drug targets. Last year the companies expanded the pact to encompass 15 targets, which excludes Tango’s three lead candidates. Tango and BCTG have scheduled a conference call today at 10 a.m. E.T. Price Action: BCTG shares are up 5.26% at $11.80 on the last check Wednesday. See more from BenzingaClick here for options trades from BenzingaaTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810Moleculin Biotech Stock Is Trading Higher After WP1066 Scores Rare Pediatric Disease Tag For Type Of Brain Tumor© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.